Table of Contents
<< Previous Issue | Aug 2020 (Vol: 2020, Issue: 8) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Sanofi Acquires Principia for US$3.68 B
-
J&J Focuses on Immunology with US$6.5 B Momenta Buyout
- Section: Research & Development
-
Genentech Pays US$120 M Upfront for UCB’s Tau-targeting Antibody UCB0107
-
Gilead Expands Deal and Triples Tango Targets to 15